| |
| |
|
| Insider
Information: |
Dunsire Deborah |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
27,730 |
|
|
Indirect Shares
|
70,681 |
|
|
| Direct
Value |
$913,175 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
98,411 |
|
|
| Total
Value |
$913,175 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Millennium Pharmaceuticals Inc |
MLNM |
President, CEO, Director |
2008-05-14 |
0 |
2008-04-24 |
70,681 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
Director |
2023-06-07 |
19,730 |
2017-06-22 |
0 |
Premium* |
|
|
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2021-07-21 |
0 |
2018-02-08 |
0 |
Premium* |
|
|
Syros Pharmaceuticals, Inc. |
SYRS |
Director |
2022-09-16 |
8,000 |
2022-09-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2023-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,860 |
19,730 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2022-09-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
8,000 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2022-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,300 |
15,870 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2021-07-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(14,629) |
0 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2021-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,145 |
12,570 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,495 |
14,629 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2020-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
4,409 |
12,134 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2019-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
7,875 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2019-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,466 |
7,725 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2018-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
4,875 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2018-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,174 |
4,259 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2018-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,085 |
2,085 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2017-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
1,875 |
1,875 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
President, CEO |
• • – |
2008-05-14 |
4 |
D |
$25.00 |
$17,223,925 |
D/D |
(688,957) |
0 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
President, CEO |
• • – |
2008-05-09 |
4 |
D |
$25.00 |
$1,205,450 |
D/D |
(48,218) |
688,957 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
President, CEO |
• • – |
2008-04-24 |
4 |
GA |
$0.00 |
$0 |
I/I |
68,899 |
68,899 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
President, CEO |
• • – |
2008-04-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
68,899 |
737,175 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
President and CEO |
• • – |
2008-03-07 |
4 |
AS |
$13.34 |
$188,036 |
D/D |
(14,096) |
806,074 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
President and CEO |
• • – |
2008-02-29 |
4 |
AS |
$13.67 |
$325,660 |
D/D |
(23,820) |
820,170 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
President and CEO |
• • – |
2008-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
143,890 |
843,990 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
President and CEO |
• • – |
2007-07-19 |
4 |
AS |
$10.61 |
$357,175 |
D/D |
(33,664) |
700,100 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
President and CEO |
• • – |
2007-03-08 |
4 |
AS |
$10.41 |
$112,126 |
D/D |
(10,771) |
733,764 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
President and CEO |
• • – |
2007-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
211,200 |
744,535 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
President and CEO |
• • – |
2006-10-27 |
4 |
AS |
$11.50 |
$1,293,972 |
D/D |
(112,500) |
533,335 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
President and CEO |
• • – |
2006-10-27 |
4 |
OE |
$9.33 |
$1,099,500 |
D/D |
112,500 |
645,835 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
